Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc.
| Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. |
| Ascent Pharmaceuticals, Inc. |
| 2:2023cv03372 |
| May 4, 2023 |
| US District Court for the Eastern District of New York |
| Joan M Azrack |
| Steven Tiscione |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 30, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 NOTICE of Voluntary Dismissal by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. without prejudice (Leonard, Jason) |
| Filing 6 Corporate Disclosure Statement by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc.; Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Other Affiliate Astellas B.V., Other Affiliate Astellas US Holding, Inc. for Astellas Pharma Inc.. (Leonard, Jason) |
| Filing 5 Summons Issued as to Ascent Pharmaceuticals, Inc. (LJ) |
| Filing 4 Notice of Report on the filing of an action regarding a Patent. (Attachments: #1 Complaint, #2 Exhibit A - U.S. Patent No. 10,842,780) (LJ) |
| Filing 3 In accordance with Rule 73 of the Federal Rules of Civil Procedure and Local Rule 73.1, the parties are notified that if all parties consent a United States magistrate judge of this court is available to conduct all proceedings in this civil action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to the Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. The form may also be accessed at the following link: #http://www.uscourts.gov/uscourts/FormsAndFees/Forms/AO085.pdf. You may withhold your consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent. (LJ) |
| Filing 2 This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (LJ) |
| Filing 1 COMPLAINT against Ascent Pharmaceuticals, Inc. filing fee $ 402, receipt number ANYEDC-16666514 Was the Disclosure Statement on Civil Cover Sheet completed -YES,, filed by Astellas Pharma Inc., Astellas Pharma Global Development, Inc., Astellas Ireland Co., Ltd.. (Attachments: #1 Exhibit A -- U.S. Patent No. 10,842,780, #2 Civil Cover Sheet, #3 Civil Cover Sheet Attachment of Related Cases to Civil Cover Sheet, #4 Proposed Summons to Ascent Pharmaceuticals, Inc.) (Leonard, Jason) |
| Case Assigned to Judge Joan M. Azrack and Magistrate Judge Steven Tiscione. Please download and review the Individual Practices of the assigned Judges, located on our #website. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (LJ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
